Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
20%
OVERLAP
BY WEIGHT
27
# OF OVERLAPPING
HOLDINGS
XLV
59
HOLDINGS
46%
ALSO IN JDOC
JDOC
66
HOLDINGS
48%
ALSO IN XLV
SECTOR DRIFT (XLV minus JDOC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in JDOC |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 15.7% | 2.6% | 2.6% | |
| ABBVIE INC | 7.4% | 2.3% | 2.3% | |
| UNITEDHEALTH GROUP INC | 5.6% | 2.1% | 2.1% | |
| JOHNSON & JOHNSON | 10.3% | 1.5% | 1.5% | |
| MERCK & CO. INC. | 6.0% | 1.5% | 1.5% | |
XLV Overweight Relative to JDOC
| ELI LILLY & CO | 13.2% | |
| JOHNSON & JOHNSON | 8.8% | |
| ABBVIE INC | 5.1% | |
| MERCK & CO. INC. | 4.5% | |
| AMGEN INC | 3.8% | |
| UNITEDHEALTH GROUP INC | 3.5% | |
| GILEAD SCIENCES INC | 2.9% | |
| ABBOTT LABORATORIES | 2.9% | |
| THERMO FISHER SCIENTIFIC INC | 2.7% | |
| PFIZER INC | 2.5% |
XLV Underweight Relative to JDOC
| ASTRAZENECA PLC | -1.3% | |
| ARGEN-X SE | -0.8% | |
| GSK PLC | -0.8% | |
| NOVO NORDISK A/S-B | -0.8% | |
| UCB SA | -0.7% | |
| NOVARTIS AG | -0.5% | |
| HOYA CORP | -0.4% | |
| TEVA PHARMACEUTICAL IND LTD | -0.4% | |
| TAKEDA PHARMACEUTICAL CO LTD | -0.4% | |
| FRESENIUS SE | -0.3% |